IL6 and colitis: In addition to these effects, RES administration suppressed the expressions of MCP-1, cytokine-induced neutrophil chemoattractant 1 (CINC-1), TNF-α, IL-1β, IL-6 and IL-12 in rats with TNBS-induced colitis [92].